Prediction of carboplatin clearance from standard morphological and biological patient characteristics

被引：19

作者：

Fujiwara, Y

Takahashi, T

Yamakido, M

Ohune, T

Tsuya, T

Egorin, MJ

机构：

[1] UNIV MARYLAND,SCH MED,CTR CANC,BALTIMORE,MD 21201

[2] KURE ROSAI GEN HOSP,KURE,JAPAN

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1997年 / 89卷 / 03期

关键词：

D O I：

10.1093/jnci/89.3.260-a

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：260 / 261

页数：2

共 10 条

[1] CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION [J].

CALVERT, AH ;

NEWELL, DR ;

GUMBRELL, LA ;

OREILLY, S ;

BURNELL, M ;

BOXALL, FE ;

SIDDIK, ZH ;

JUDSON, IR ;

GORE, ME ;

WILTSHAW, E .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1748-1756

[2] Population pharmacokinetics of carboplatin in children [J].

Chatelut, E ;

Boddy, AV ;

Peng, B ;

Rubie, H ;

Lavit, M ;

Dezeuze, A ;

Pearson, ADJ ;

Roche, H ;

Robert, A ;

Newell, DR ;

Canal, P .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (04) :436-443

[3] PREDICTION OF CARBOPLATIN CLEARANCE FROM STANDARD MORPHOLOGICAL AND BIOLOGICAL PATIENT CHARACTERISTICS [J].

CHATELUT, E ;

CANAL, P ;

BRUNNER, V ;

CHEVREAU, C ;

PUJOL, A ;

BONEU, A ;

ROCHE, H ;

HOUIN, G ;

BUGAT, R .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (08) :573-580

[4] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].

COCKCROFT, DW ;

GAULT, MH .

NEPHRON, 1976, 16 (01) :31-41

[5] PROGRAM PACKAGE FOR SIMULATION AND PARAMETER-ESTIMATION IN PHARMACOKINETIC SYSTEMS [J].

DARGENIO, DZ ;

SCHUMITZKY, A .

COMPUTER PROGRAMS IN BIOMEDICINE, 1979, 9 (02) :115-134

[6] VALIDITY OF CREATININE CLEARANCE ESTIMATES IN THE ASSESSMENT OF RENAL-FUNCTION [J].

LUKE, DR ;

HALSTENSON, CE ;

OPSAHL, JA ;

MATZKE, GR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (05) :503-508

[7] PHASE-I STUDY AND CLINICAL PHARMACOLOGICAL EVALUATION OF DAILY ORAL ETOPOSIDE COMBINED WITH CARBOPLATIN IN PATIENTS WITH LUNG-CANCER [J].

OHUNE, T ;

FUJIWARA, Y ;

SUMIYOSHI, H ;

YAMAOKA, N ;

YAMAKIDO, M .

JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (05) :490-500

[8]

PERRONE RD, 1992, CLIN CHEM, V38, P1933

[9] SOME SUGGESTIONS FOR MEASURING PREDICTIVE PERFORMANCE [J].

SHEINER, LB ;

BEAL, SL .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (04) :503-512

[10] Pharmacokinetics and pharmacodynamics of carboplatin administered in a high-dose combination regimen with thiotepa, cyclophosphamide and peripheral stem cell support [J].

vanWarmerdam, LJC ;

Rodenhuis, S ;

vanderWall, E ;

Maes, RAA ;

Beijnen, JH .

BRITISH JOURNAL OF CANCER, 1996, 73 (08) :979-984

← 1 →